Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.060
-0.060 (-5.36%)
At close: Nov 21, 2024, 4:00 PM
1.090
+0.030 (2.83%)
After-hours: Nov 21, 2024, 6:36 PM EST

Heron Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1612552979311,9232,116
Upgrade
Market Cap Growth
108.18%-14.16%-68.06%-51.60%-9.13%4.57%
Upgrade
Enterprise Value
2783583338921,6901,878
Upgrade
Last Close Price
1.121.702.509.1321.1623.50
Upgrade
PS Ratio
1.242.012.7610.7821.6914.50
Upgrade
PB Ratio
-7.54-7.5121.9012.008.135.24
Upgrade
P/TBV Ratio
--21.9012.008.135.24
Upgrade
EV/Sales Ratio
2.022.823.1010.3319.0612.86
Upgrade
Debt / Equity Ratio
-4.46-5.2911.602.060.100.05
Upgrade
Asset Turnover
0.610.540.390.260.200.30
Upgrade
Inventory Turnover
1.652.423.073.896.277.16
Upgrade
Quick Ratio
1.611.761.662.722.444.46
Upgrade
Current Ratio
2.282.372.493.583.074.95
Upgrade
Return on Equity (ROE)
---399.43%-140.53%-70.99%-52.91%
Upgrade
Return on Assets (ROA)
-2.31%-24.56%-38.01%-41.04%-32.11%-27.01%
Upgrade
Return on Capital (ROIC)
-3.58%-36.71%-51.84%-54.31%-40.63%-32.99%
Upgrade
Earnings Yield
-17.10%-43.34%-61.24%-23.71%-11.82%-9.68%
Upgrade
FCF Yield
-5.88%-23.65%-50.04%-22.17%-9.97%-6.22%
Upgrade
Buyback Yield / Dilution
-16.83%-26.87%-10.57%-8.48%-11.00%-11.73%
Upgrade
Total Shareholder Return
-16.83%-26.87%-10.57%-8.48%-11.00%-11.73%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.